4.7 Article

Behavioral Effects of a Synthetic Agonist Selective for Nociceptin/Orphanin FQ Peptide Receptors in Monkeys

期刊

NEUROPSYCHOPHARMACOLOGY
卷 34, 期 9, 页码 2088-2096

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/npp.2009.33

关键词

opioid; antinociception; self-administration; analgesic; abuse liability

资金

  1. US Department of Defense
  2. US Public Health Service [DA-015449]
  3. [W81XWH-071-0162]

向作者/读者索取更多资源

Behavioral effects of a nonpeptidic NOP (nociceptin/orphanin FQ Peptide) receptor agonist, Ro 64-6198, have not been studied in primate species. The aim of the study was to verify the receptor mechanism underlying the behavioral effects of Ro 64-6198 and to systematically compare behavioral effects of Ro 64-6198 with those of a mu-opioid receptor agonist, alfentanil, in monkeys. Both Ro 64-6198 (0.001-0.06 mg/kg, s.c.) and alfentanil (0.001-0.06 mg/kg, s.c.) produced antinociception against an acute noxious stimulus (50 degrees C water) and capsaicin-induced allodynia. An NOP receptor antagonist, J-113397 (0.01-0.1 mg/kg, s.c.), dose-dependently produced rightward shifts of the dose-response curve of Ro 64-6198-induced antinociception. The apparent pA(2) value of J-113397 was 8.0. Antagonist studies using J-113397 and naltrexone revealed that Ro 64-6198 produced NOP receptor-mediated antinociception independent of mu-opioid receptors. In addition, alfentanil dose-dependently produced respiratory depression and itch/scratching responses, but antinociceptive doses of Ro 64-6198 did not produce such effects. More important, Ro 64-6198 did not produce reinforcing effects comparable with those of alfentanil, cocaine, or methohexital under self-administration procedures in monkeys. These results provide the first functional evidence that the activation of NOP receptors produces antinociception without reinforcing effects in primates. Non-peptidic NOP receptor agonists may have therapeutic value as novel analgesics without abuse liability in humans. Neuropsychopharmacology (2009) 34, 2088-2096; doi:10.1038/npp.2009.33; published online 11 March 2009

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Chemistry, Medicinal

Nociceptin/Orphanin FQ Peptide Receptor-Related Ligands as Novel Analgesics

Norikazu Kiguchi, Huiping Ding, Shiroh Kishioka, Mei-Chuan Ko

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2020)

Review Neurosciences

Therapeutic potentials of NOP and MOP receptor coactivation for the treatment of pain and opioid abuse

Norikazu Kiguchi, Huiping Ding, Mei-Chuan Ko

Summary: This article discusses the functional profiles of ligands with dual NOP and MOP receptor agonist activities and highlights their advantages in pain relief and drug abuse treatment. By coactivating NOP and MOP receptors, these ligands demonstrate a wider therapeutic window and fewer side effects.

JOURNAL OF NEUROSCIENCE RESEARCH (2022)

Article Cell Biology

Periostin Activation of Integrin Receptors on Sensory Neurons Induces Allergic Itch

Santosh K. Mishra, Joshua J. Wheeler, Saumitra Pitake, Huiping Ding, Changyu Jiang, Tomoki Fukuyama, Judy S. Paps, Patrick Ralph, Jacob Coyne, Michelle Parkington, Jennifer DeBrecht, Lauren C. Ehrhardt-Humbert, Glenn P. Cruse, Wolfgang Baeumer, Ru-Rong Ji, Mei-Chuan Ko, Thierry Olivry

CELL REPORTS (2020)

Article Multidisciplinary Sciences

STING controls nociception via type I interferon signalling in sensory neurons

Christopher R. Donnelly, Changyu Jiang, Amanda S. Andriessen, Kaiyuan Wang, Zilong Wang, Huiping Ding, Junli Zhao, Xin Luo, Michael S. Lee, Yu L. Lei, William Maixner, Mei-Chuan Ko, Ru-Rong Ji

Summary: STING is a critical immune regulator that induces type-I interferons and other cytokines to promote immune-cell-mediated clearance of pathogens and neoplastic cells. STING also plays a role in antitumour immunity and has potential as a target for cancer immunotherapy. Additionally, STING is shown to regulate nociception through IFN-I signaling, leading to pain relief in mice and non-human primates.

NATURE (2021)

Article Cell Biology

Morphine acts on spinal dynorphin neurons to cause itch through disinhibition

Eileen Nguyen, Grace Lim, Huiping Ding, Junichi Hachisuka, Mei-Chuan Ko, Sarah E. Ross

Summary: The study found that morphine-induced itch is caused by neurons rather than mast cells, and spinal dynorphin neurons play an important role in mice. Agonism of the kappa-opioid receptor can alleviate morphine-induced itch, challenging the long-standing use of antihistamines.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Review Neurosciences

Translational value of non-human primates in opioid research

Huiping Ding, Mei-Chuan Ko

Summary: NHP models have been instrumental in opioid research for over five decades, offering more accurate conclusions in areas such as analgesia, abuse liability, and respiratory depression. Recent studies suggest that mixed mu opioid and nociceptin/orphanin FQ peptide receptor partial agonists may serve as safe, non-addictive analgesics.

EXPERIMENTAL NEUROLOGY (2021)

Article Gastroenterology & Hepatology

Epithelia-Sensory Neuron Cross Talk Underlies Cholestatic Itch Induced by Lysophosphatidylcholine

Yong Chen, Zi-Long Wang, Michele Yeo, Qiao-Juan Zhang, Ana E. Lopez-Romero, Hui-Ping Ding, Xin Zhang, Qian Zeng, Sara L. Morales-Lazaro, Carlene Moore, Ying-Ai Jin, Huang-He Yang, Johannes Morstein, Andrey Bortsov, Marcin Krawczyk, Frank Lammert, Manal Abdelmalek, Anna Mae Diehl, Piotr Milkiewicz, Andreas E. Kremer, Jennifer Y. Zhang, Andrea Nackley, Tony E. Reeves, Mei-Chuan Ko, Ru-Rong Ji, Tamara Rosenbaum, Wolfgang Liedtke

Summary: The study identified LPC as a novel pruritogen in cholestatic liver diseases, causing itch through epithelia-sensory neuron cross talk. This finding provides a new perspective for the treatment of itch.

GASTROENTEROLOGY (2021)

Article Pharmacology & Pharmacy

Chemogenetic activation of central gastrin-releasing peptide-expressing neurons elicits itch-related scratching behavior in male and female mice

Norikazu Kiguchi, Yohji Fukazawa, Ayano Saika, Daisuke Uta, Fumihiro Saika, Tomoe Y. Nakamura, Mei-Chuan Ko, Shiroh Kishioka

Summary: This study investigated the direct modulation of itch processing by central GRP(+) neurons in the CNS. The results suggest that central GRP(+) neurons play important roles in itch processing, with no significant sex differences observed, providing new insights for further research on the functional roles of itch-related neurons and the development of treatment strategies.

PHARMACOLOGY RESEARCH & PERSPECTIVES (2021)

Article Anesthesiology

Functional Profile of Systemic and Intrathecal Cebranopadol in Nonhuman Primates

Huiping Ding, Claudio Trapella, Norikazu Kiguchi, Fang-Chi Hsu, Girolamo Calo, Mei-Chuan Ko

Summary: Cebranopadol exhibits potent antinociceptive effects by mainly activating mu receptors in nonhuman primates, with reduced side effects including lack of respiratory depression and pruritus. Despite displaying decreased reinforcing strength compared to fentanyl, caution is warranted due to detectable reinforcing effects, emphasizing the importance of careful development and clinical use of cebranopadol.

ANESTHESIOLOGY (2021)

Article Pharmacology & Pharmacy

Usefulness of the measurement of neurite outgrowth of primary sensory neurons to study cancer-related painful complications

Sun H. Park, Matthew R. Eber, Miriam M. Fonseca, Chirayu M. Patel, Katharine A. Cunnane, Huiping Ding, Fang-Chi Hsu, Christopher M. Peters, Mei-Chuan Ko, Roy E. Strowd, John A. Wilson, Wesley Hsu, E. Alfonso Romero-Sandoval, Yusuke Shiozawa

Summary: Abnormal growth of sensory nerves contributes to cancer-related pain. Primary neuronal cultures from DRG are commonly used to study pain signaling. In this study, DRG sensory neurons from different species were established in serum-free conditions and showed altered neurite growth in response to cancer-derived factors and chemotherapeutic agents. Furthermore, a quantification method was developed to measure neurite length accurately and efficiently. Exogenous factors also affected gene expression in sensory neurons.

BIOCHEMICAL PHARMACOLOGY (2021)

Article Neurosciences

IL-23/IL-17A/TRPV1 axis produces mechanical pain via macrophage-sensory neuron crosstalk in female mice

Xin Luo, Ouyang Chen, Zilong Wang, Sangsu Bang, Jasmine Ji, Sang Hoon Lee, Yul Huh, Kenta Furutani, Qianru He, Xueshu Tao, Mei-Chuan Ko, Andrey Bortsov, Christopher R. Donnelly, Yong Chen, Andrea Nackley, Temugin Berta, Ru-Rong Ji

Summary: The IL-23/IL-17A/TRPV1 axis regulates female-specific mechanical pain, with IL-23 inducing pain in females but impaired in mice lacking IL-23 or IL-23r. IL-23-induced pain is promoted by estrogen and suppressed by androgen.

NEURON (2021)

Article Pharmacology & Pharmacy

Functional roles of neuromedin B and gastrin-releasing peptide in regulating itch and pain in the spinal cord of non-human primates

Norikazu Kiguchi, Huiping Ding, Sun H. Park, Kelsey M. Mabry, Shiroh Kishioka, Yusuke Shiozawa, E. Alfonso Romero-Sandoval, Christopher M. Peters, Mei-Chuan Ko

Summary: This study aimed to compare the expression patterns of neuromedin B (NMB) and its receptor (NMBR) and the effects of NMB and gastrin-releasing peptide (GRP) on itch and pain in non-human primates (NHPs). The results showed that the NMB-NMBR system has minimal functional role in itch and pain neurotransmission in primates, while GRP elicited significant scratching responses. Drugs targeting the spinal NMB-NMBR system may not effectively alleviate non-NMBR-mediated itch.

BIOCHEMICAL PHARMACOLOGY (2022)

Article Behavioral Sciences

Enhanced antidepressant-like effects of a delta opioid receptor agonist, SNC80, in rats under inflammatory pain

Chang-Ming Chen, Huiping Ding, Kelsey M. Mabry, Mei-Chuan Ko

Summary: This study compared the antidepressant-like effects of a delta opioid receptor (DOR) agonist, SNC80, and a tricyclic antidepressant, amitriptyline, in rats under normal or inflammatory pain state. The results showed that the potency of SNC80-induced antidepressant-like effects, but not amitriptyline, was enhanced in rats under inflammatory pain. This suggests that DOR agonists may be more effective as potential antidepressants for patients experiencing both depression and pain.

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2022)

Article Neurosciences

Functional consequences of short-term exposure to opioids versus cannabinoids in nonhuman primates

Huiping Ding, Norikazu Kiguchi, Kelsey M. Mabry, Shiroh Kishioka, Mei-Chuan Ko

Summary: In nonhuman primates, opioids and cannabinoids have comparable analgesic effects, but only opioids cause physical dependence at their analgesic doses.

NEUROPHARMACOLOGY (2023)

Review Pharmacology & Pharmacy

Nociceptin Receptor-Related Agonists as Safe and Non-addictive Analgesics

Huiping Ding, Norikazu Kiguchi, MaryBeth Dobbins, E. Alfonso Romero-Sandoval, Shiroh Kishioka, Mei-Chuan Ko

Summary: As currently available opioid analgesics often have dose-limiting adverse effects, new approaches have been pursued to develop safe and non-addictive pain medications. NOP receptor-related agonists have emerged as a promising target for developing novel opioids that modulate the analgesic and addictive properties of MOP receptor agonists. Several lines of evidence suggest that peptidic and non-peptidic NOP receptor agonists and mixed NOP/MOP receptor partial agonists show potent analgesic effects in experimental animal models without eliciting adverse effects.
暂无数据